Biogen Idec
Profile Unclaimed

Biogen Idec Photos

Exterior RTP
Bird's Eye View
Interior RTP

+ Add Photo

Biogen Idec Reviews

249 Reviews
249 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Biogen Idec CEO and Director George A. Scangos
George A. Scangos
144 Ratings

Biogen Idec Interviews

Updated 5 Feb 2015
Updated 5 Feb 2015

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Manufacturing Associate Interview

    Anonymous Interview Candidate in Research Triangle Park, NC (US)
    Anonymous Interview Candidate in Research Triangle Park, NC (US)
    Application Details

    I applied through a staffing agency – interviewed at Biogen Idec.

    Interview Details

    The interview process was brief, round robin style with 4 managers and 4 interview candidates, 15 mins with each manager. Be able to elaborate on anything you put on your resume, examples of skill use and definitions of processes. The interviewing managers were all very nice and professional but two of them had poker faces the entire time and were very intimidating. They seemed to appreciate my positivity and enthusiasm, the other candidates were quiet with no expressions and seemed scared, I don't think they made it. Overall positive experience. Questions were fair and not meant to be tricky. Have questions to ask for each person! From application to interview took 2 weeks, from interview to offer took 1 week, from offer to first day took 1 month.

    Interview Questions
    • What do you know about Biogen?
      Define what being a leader means to you.
      Answer Question
    Negotiation Details
    Asked for relocation assistance but was denied. Accepted anyways.
    Accepted Offer
    Positive Experience
    Average Interview

Biogen Idec Awards and Accolades

Something missing? Add an award
Top Employer, Science Magazine, 2012
Top Employer, Science Magazine, 2011
Show More

Additional Info

Unlock Profile
Headquarters Cambridge, MA
Size 5000+ Employees
Founded 1978
Type Company - Public (BIIB)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 billion (AUD) per year
Competitors Unknown

With its pipeline full of biotech drugs, Biogen Idec aims to meet the unmet needs of patients around the world. The biotech giant is focused on developing treatments in the areas of immunology and neurology. Its product roster includes best-selling Avonex, a popular drug for the treatment of relapsing multiple sclerosis (MS); Tysabri, a drug treatment for MS and Crohn's disease (developed with Elan); Rituxan, a monoclonal antibody developed jointly with Genentech that treats non-Hodgkin's lymphoma and rheumatoid arthritis; and Fumaderm, a psoriasis drug marketed in... More

Work at Biogen Idec? Share Your Experiences

Biogen Idec

Click to Rate